Connect your AI

Pulmonx Corporation LUNG Stock-Based Comp

Stock-Based Comp at other companies

Intuitive SurgicalISRG

$209.5M+13.1%

Theravance BiopharmaTBPH

$4.5M-7.6%

SavaraSVRA

$10.73M+261%

LQD

Liquidia CorporationLQDA

$9.22M+23.9%

United TherapeuticsUTHR

$33.9M+6.6%

Viemed Healthcare, Inc.VMD

$2.45M+6.1%

Other financials

Income statement

Revenue$20.6M-8.7%

Gross profit$16.0M-1.8%

Operating income-$13.0M+11.0%

Net income-$13.7M+5.5%

EPS (diluted)-$0.33+8.3%

Balance sheet

Cash & equivalents$61.0M-2.4%

Total debt$56.3M-1.2%

Total equity$45.8M-41.1%

Total assets$120.0M-20.4%

Cash flow

Operating cash flow-$10.1M+23.6%

CapEx$9.0K-97.0%

Free cash flow-$10.1M+25.3%

Valuation

Market cap$54.91M-43.7%

Enterprise value$50.17M-39.2%

P/S0.6×-0.5×

Profitability

Gross margin75.5%+2.0pp

Operating margin-58.8%-5.8pp

Net margin-60.1%-4.4pp

FCF margin-33.2%-4.4pp

Returns & leverage

Return on equity-86.2%+62.6pp

Debt / equity1.2×+0.5×

Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pulmonx Corporation's stock-based comp?: Pulmonx Corporation (LUNG) reported stock-based comp of $4.14M in Q1 2026.
How has Pulmonx Corporation's stock-based comp changed year-over-year?: Pulmonx Corporation's stock-based comp decreased by 26.3% year-over-year, from $5.61M to $4.14M.
What is the long-term trend for Pulmonx Corporation's stock-based comp?: Over 4 years (2021 to 2025), Pulmonx Corporation's stock-based comp has grown at a 19.2% compound annual growth rate (CAGR), from $10.53M to $21.23M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.